-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - larger, higher-quality studies have almost all
been conducted with new drugs with
pharmaceutical company
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
January 01, 2010 - Saunders Company; 1997. p. 726-39.
8. Skoner DP, Rachelefsky GS, Meltzer EO, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
March 11, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: March 11, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or
Hyperthyroidism
I. Background and Objectives for th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/partial-breast-irradiation-disposition-comments.pdf
January 31, 2023 - Partial Breast Irradiation for Breast Cancer
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Partial Breast Irradiation for Breast Cancer
Draft report available for public comment from July 1, 2022, to July 29, 2022.
Citation: Shumway DA, Corbin KS…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - reduction of
cardiovascular death and MI
in patients with ACS
Angiomax
Bivalirudin The Medicines
Company … approved for patients
with unstable angina
undergoing PTCA
Pletal Cilostazol Otsuka
Pharmaceutical
Company
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - in Germany were
contacted by mail (mailing lists
were obtained from the
Siemans Health Insurance
Company … campus of Beijing
Institute of Technology)
Synchronous ZD-10, Beijing Maidakang Medical
Equipment Company
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
February 01, 2019 - (Prepared by the Outcome
DEcIDE Center [Outcome Sciences, Inc., a
Quintiles company] under Contract … based at NIH (3 NCI, 1
NIDDK), 3 at university-based
cancer centers (funding unclear),
one pharma company
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
June 01, 2010 - (a Johnson & Johnson company); Pfizer, Inc.;
and GlaxoSmithKline.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
December 01, 2011 - Hopefully not influenced by drug company marketing
efforts to differentiate their drugs!
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
July 01, 2010 - Saunders Company; 1998. p. 615-23.
6. U.S. Preventive Services Task Force.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-web-interactive-presentation.pdf
September 01, 2019 - A first look at graph
theory: World Scientific Publishing
Company; 1991.
16.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
May 26, 2015 - worker-health-protocol-150526
Evidence-based Practice Center Systematic Review Protocol
Project Title: Total Worker Health
I. Background and Objectives for the Systematic Review
Workplac…
-
effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
January 01, 2012 - Arthritis and Nontraumatic Joint Disease
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 01: Arthritis and Nontraumatic Joint
Disease
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 G…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - 1
Comparative Effectiveness Review
Number 150
Decisional Dilemmas in Discontinuing
Prolonged Disease-Modifying Treatment for
Multiple Sclerosis
Executive Summary
Background
Multiple sclerosis (MS) is a variably
debilitating disease characterized by
demyelination (deterioration of the
protective myelin sheat…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/telehealth_disposition-comments.pdf
June 30, 2016 - percent with
a Remote Patient Monitoring-
Enabled Program, Case Study
by Care Innovations, an Intel GE
Company
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
September 01, 2008 - [Identifying information redacted] is a biopharmaceutical company dedicated to improving patient lives
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_disposition-comments.pdf
January 26, 2015 - The company
at the time (Ortho) decided for political reasons to try for an
indication for pain rather
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_executive.pdf
October 01, 2011 - Layout 1
Background
Mildly elevated or decreased serum thyroid
stimulating hormone (TSH, also called
thyrotropin) levels are the most common
abnormalities related to thyroid function.
Subclinical thyroid dysfunction, defined as
an abnormal TSH with normal levels of
serum thyroid hormones (T3 and T4),
affects 5 perc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
January 01, 2007 - Layout 1
Background
Rheumatoid and psoriatic arthritis are
among the most disabling forms of
arthritis. Rheumatoid arthritis (RA), which
affects 1 percent of the U.S. adult
population (or upwards of 2 million
individuals), is an autoimmune disease that
involves inflammation of the synovium (a
thin layer of tissue lin…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-how-to-webinar-text-only.pdf
December 06, 2011 - Using Deliberative Methods to Engage Patients, Consumers, and the Public
Slide 1
Using Deliberative Methods to Engage Patients, Consumers, and
the Public
Agency for Healthcare Research and Quality
Community Forum
December 6, 2011
Speaker notes: Welcome, everyone, to this webinar about using deliberative met…